Dec 22 2015
EDAP TMS SA, the global leader in therapeutic ultrasound, today announced the sale of an Ablatherm Robotic HIFU device to Sylvester Comprehensive Cancer Center, part of UHealth – the University of Miami Health System.
Dipen J. Parekh, M.D., a robotic surgeon and urologic oncologist at Sylvester, commented: “We are pleased to add Ablatherm Robotic HIFU to our range of prostate ablation tools, as it complements our existing strength in robotic surgery.” Parekh, who is also professor and chair of the Department of Urology and director of Robotic Surgery at the University of Miami Miller School of Medicine adds, “With the recent FDA clearance of HIFU for prostate tissue ablation, this is an exciting time for the urology community and an opportunity to make a meaningful difference in the lives of prostate cancer patients. This is a truly non-invasive technique with the potential of significantly reduced side effects related to surgery and radiation. We look forward to working with EDAP to bring the system online and initiating patient treatments.”
Marc Oczachowski, EDAP TMS Chief Executive Officer, added: “We are excited to have Sylvester and the University of Miami’s Department of Urology among the first academic users of Ablatherm Robotic HIFU in the U.S. This sale is extremely important in our U.S. expansion strategy, which is focused on collaborating with leading academic and scientific centers to further establish the technology and accelerate its clinical recognition. We are honored to be working with such a respected robotic surgeon, urologist and Gold Cystoscope winner as Dr. Dipen Parekh and are looking forward to supporting him and his team.”